ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 98 filers reported holding ABEONA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $452,000 | -73.0% | 200,000 | -42.9% | 0.03% | -70.8% |
| Q2 2019 | $1,673,000 | -43.2% | 350,000 | -12.5% | 0.10% | -51.8% |
| Q1 2019 | $2,944,000 | -15.6% | 400,000 | -18.1% | 0.20% | -29.7% |
| Q4 2018 | $3,488,000 | -45.5% | 488,534 | -2.3% | 0.28% | -32.0% |
| Q3 2018 | $6,400,000 | -27.2% | 500,000 | -9.0% | 0.42% | -36.0% |
| Q2 2018 | $8,790,000 | +11.5% | 549,404 | 0.0% | 0.65% | +10.5% |
| Q1 2018 | $7,884,000 | -13.5% | 549,404 | -4.5% | 0.59% | -38.4% |
| Q4 2017 | $9,114,000 | +33.6% | 575,000 | +43.8% | 0.95% | -20.8% |
| Q3 2017 | $6,820,000 | +166.4% | 400,000 | 0.0% | 1.20% | +184.0% |
| Q2 2017 | $2,560,000 | +28.0% | 400,000 | 0.0% | 0.42% | +46.2% |
| Q1 2017 | $2,000,000 | -17.5% | 400,000 | -20.0% | 0.29% | -11.3% |
| Q4 2016 | $2,425,000 | – | 500,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,359,767 | $11,445,000 | 20.08% |
| NEXTHERA CAPITAL LP | 568,573 | $2,758,000 | 1.62% |
| Kavi Asset Management, LP | 365,600 | $1,773,000 | 1.30% |
| Opaleye Management Inc. | 400,000 | $1,940,000 | 1.14% |
| RA Capital Management | 1,142,857 | $5,543,000 | 0.78% |
| Castle Hook Partners LP | 349,800 | $1,697,000 | 0.38% |
| Cormorant Asset Management, LP | 500,000 | $2,425,000 | 0.33% |
| DAFNA Capital Management LLC | 76,800 | $372,000 | 0.33% |
| Perceptive Advisors | 842,173 | $4,085,000 | 0.29% |
| Soros Fund Management | 896,642 | $4,349,000 | 0.10% |